HHH syndrome
HHH Syndrome (Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome) is a rare autosomal recessive metabolic disorder characterized by an inability to properly process the amino acid ornithine. The syndrome was first described in 1969 by three Canadian researchers, Hayasaka, Harper, and Haworth, from whom the syndrome gets its name.
Symptoms and Signs[edit | edit source]
The symptoms of HHH syndrome can vary widely among affected individuals. They typically include neurological problems such as developmental delay, intellectual disability, seizures, ataxia (lack of muscle control), and hyperreflexia (overactive reflexes). Other symptoms can include hepatomegaly (enlarged liver), coagulopathy (blood clotting disorder), and pulmonary symptoms such as hyperventilation.
Causes[edit | edit source]
HHH syndrome is caused by mutations in the SLC25A15 gene, which provides instructions for making a protein that is primarily found in the liver and kidneys. This protein is involved in the urea cycle, a series of reactions that occur in liver cells. The urea cycle processes excess nitrogen, generated when protein is used by the body, to make a compound called urea that is excreted in the urine.
Diagnosis[edit | edit source]
Diagnosis of HHH syndrome is based on the presence of characteristic symptoms, a detailed patient history, a thorough clinical evaluation, and a variety of specialized tests. These tests can include blood tests, urine tests, and genetic testing.
Treatment[edit | edit source]
Treatment of HHH syndrome is aimed at managing the symptoms and preventing complications. This can include a low-protein diet, medications to reduce the level of ammonia in the blood, and in some cases, liver transplantation.
Prognosis[edit | edit source]
The prognosis for individuals with HHH syndrome varies. Some individuals have a normal lifespan with treatment, while others may have severe neurological impairment and life-threatening metabolic crises.
See Also[edit | edit source]
HHH syndrome Resources | |
---|---|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD